Invention Grant
- Patent Title: Anti-ErbB antibodies and methods of use thereof
-
Application No.: US15302342Application Date: 2015-04-10
-
Publication No.: US10745490B2Publication Date: 2020-08-18
- Inventor: Joseph Schlessinger , Diego Alvarado , Sangwon Lee
- Applicant: Celldex Therapeutics, Inc. , Yale University
- Applicant Address: US NJ Hampton US CT New Haven
- Assignee: Celldex Therapeutics, Inc.,Yale University
- Current Assignee: Celldex Therapeutics, Inc.,Yale University
- Current Assignee Address: US NJ Hampton US CT New Haven
- Agency: Jones Day
- International Application: PCT/US2015/025311 WO 20150410
- International Announcement: WO2015/157634 WO 20151015
- Main IPC: C07K16/32
- IPC: C07K16/32 ; A61K39/395 ; G01N33/74 ; A61K39/00
Abstract:
Provided herein are compositions, methods and uses involving antibodies that bind to ErbB, a receptor tyrosine kinase, and modulate the activity of ErbB. Also provided are uses and methods for treating disorders, such as cancer, by administering to subject an antibody that binds to ErbB.
Public/Granted literature
- US20170240648A1 ANTI-ERBB ANTIBODIES AND METHODS OF USE THEREOF Public/Granted day:2017-08-24
Information query
